| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $2.4M | -41.8% |
| SG&A Expense | $7.0M | +8.2% |
| Operating Income | -$9.4M | +11.3% |
| Pre-tax Income | -$10.0M | +5.6% |
| Income Tax | -$137K | — |
| Net Income | -$9.8M | +6.9% |
| EPS (Basic) | -$4.56 | -185.0% |
| EPS (Diluted) | -$4.56 | -185.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.4M | +408.7% |
| Short-term Investments | $4.0M | — |
| Current Assets | $10.1M | +583.7% |
| Total Assets | $10.1M | +583.7% |
| Total Liabilities | $1.8M | +6.1% |
| Stockholders' Equity | $8.3M | +4008.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.2M | -7.5% |
| Financing Cash Flow | $16.8M | +180.7% |